Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
SRPT

Sarepta

$56.11

1.07 (1.94%)

15:20
11/20/17
11/20
15:20
11/20/17
15:20
Options
Sarepta Therapeutics sees a bullish option play »

Sarepta Therapeutics sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

SRPT

Sarepta

$56.11

1.07 (1.94%)

07:55
11/20/17
11/20
07:55
11/20/17
07:55
Conference/Events
Sarepta has a conference call hosted by JPMorgan »

JPMorgan Analyst Rama…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

CATB

Catabasis Pharmaceuticals

$1.62

-0.03 (-1.82%)

06:17
11/20/17
11/20
06:17
11/20/17
06:17
Upgrade
Catabasis Pharmaceuticals rating change at Citi »

Catabasis Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

Friday
XENE

Xenon Pharmaceuticals

, AMGN

Amgen

$170.77

1.39 (0.82%)

14:29
11/17/17
11/17
14:29
11/17/17
14:29
Periodicals
Xenon higher as CNBC's Tirrell reports on nonaddictive pain medicines »

Six drug companies are…

XENE

Xenon Pharmaceuticals

AMGN

Amgen

$170.77

1.39 (0.82%)

RHHBY

Roche

$28.90

0.165 (0.57%)

BIIB

Biogen

$313.98

3.7 (1.19%)

RGEN

Repligen

$33.73

1.12 (3.43%)

VRTX

Vertex

$147.94

-0.72 (-0.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 30

    Nov

  • 30

    Nov

  • 02

    Dec

  • 23

    Dec

  • 03

    Feb

  • 23

    Feb

  • 30

    Apr

  • 17

    May

  • 28

    May

BLUE

bluebird bio

$160.15

3.25 (2.07%)

, AGIO

Agios Pharmaceuticals

$59.63

0.56 (0.95%)

07:14
11/17/17
11/17
07:14
11/17/17
07:14
Conference/Events
Needham to hold a tour »

Biotech Bus Tour travels…

BLUE

bluebird bio

$160.15

3.25 (2.07%)

AGIO

Agios Pharmaceuticals

$59.63

0.56 (0.95%)

SRPT

Sarepta

$55.04

0.57 (1.05%)

SAGE

Sage Therapeutics

$85.67

0.2 (0.23%)

AMAG

Amag Pharmaceuticals

$14.15

-0.05 (-0.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

  • 30

    Nov

  • 09

    Dec

  • 11

    Dec

  • 14

    Dec

  • 02

    Feb

  • 14

    Feb

  • 15

    Nov

ACOR

Acorda Therapeutics

$17.25

0.25 (1.47%)

, HLUYY

Lundbeck

$56.38

0.36 (0.64%)

07:06
11/17/17
11/17
07:06
11/17/17
07:06
Hot Stocks
Acorda announces $53M in royalty monetization transactions »

Acorda Therapeutics…

ACOR

Acorda Therapeutics

$17.25

0.25 (1.47%)

HLUYY

Lundbeck

$56.38

0.36 (0.64%)

BIIB

Biogen

$313.98

3.7 (1.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

Tuesday
BIIB

Biogen

$315.71

5.27 (1.70%)

12:04
11/14/17
11/14
12:04
11/14/17
12:04
Hot Stocks
Biogen, Theradiag sign partnership agreement »

Theradiag, a company…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNJ

Johnson & Johnson

$139.76

0.2 (0.14%)

, SSNLF

Samsung

06:20
11/14/17
11/14
06:20
11/14/17
06:20
Periodicals
J&J's Janssen drops suit against Samsung Bioepis' RA drug, Reuters reports »

Janssen Biotech, a unit…

JNJ

Johnson & Johnson

$139.76

0.2 (0.14%)

SSNLF

Samsung

BIIB

Biogen

$315.71

5.27 (1.70%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

Over a week ago
PFE

Pfizer

$35.23

0.05 (0.14%)

, BIIB

Biogen

$310.44

0.48 (0.15%)

10:35
11/13/17
11/13
10:35
11/13/17
10:35
Hot Stocks
BMO argues for Biogen as most logical takeover target for Pfizer »

Commenting on…

PFE

Pfizer

$35.23

0.05 (0.14%)

BIIB

Biogen

$310.44

0.48 (0.15%)

BMY

Bristol-Myers

$60.77

-0.09 (-0.15%)

MRK

Merck

$55.37

-0.11 (-0.20%)

AZN

AstraZeneca

$32.85

-0.06 (-0.18%)

LLY

Eli Lilly

$83.02

-0.27 (-0.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 16

    Nov

  • 28

    Nov

  • 30

    Nov

  • 14

    Dec

  • 02

    Feb

  • 05

    Mar

BIIB

Biogen

$310.44

0.48 (0.15%)

, PFE

Pfizer

$35.18

-0.02 (-0.06%)

07:29
11/13/17
11/13
07:29
11/13/17
07:29
Recommendations
Biogen, Pfizer, Bristol-Myers, Merck, AstraZeneca, Eli Lilly analyst commentary at BMO Capital »

BMO says Pfizer buying…

BIIB

Biogen

$310.44

0.48 (0.15%)

PFE

Pfizer

$35.18

-0.02 (-0.06%)

BMY

Bristol-Myers

$60.86

-1.13 (-1.82%)

MRK

Merck

$55.48

-0.73 (-1.30%)

AZN

AstraZeneca

$32.91

-0.2 (-0.60%)

LLY

Eli Lilly

$83.29

-0.7 (-0.83%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 16

    Nov

  • 28

    Nov

  • 30

    Nov

  • 14

    Dec

  • 02

    Feb

  • 05

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.